Texas SB1887 prohibits the administration of immunization products containing mRNA material, except for cancer or genetic disorder treatments.
Texas SB1887 amends the Health and Safety Code to prohibit the administration of any product containing mRNA material for immunization purposes. This prohibition does not apply to products containing mRNA material used for treating cancer or genetic disorders. The prohibition takes effect September 1, 2025, and expires September 1, 2035.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.